reVision Therapeutics, Inc.
https://www.revisiontx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From reVision Therapeutics, Inc.
Deal Watch: Visus Begins Charting Its Direction In Ophthalmology With Two Deals
Seattle biotech raised $36m series A in March, now obtains glaucoma and AMD drug candidates along with delivery technology. Alligator, Orion partner on bispecific antibodies for cancer.
EpiCept Corp.
Pain is mysteriously complex, but EpiCept has a simple approach that thwarts deep pain. By applying topical anesthetics to the surface of the skin in a proprietary patch, EpiCept has been able to relieve migraines and deep pain in the lower back. The company is also targeting surgical pain and neuropathic pain.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals